Krill Oil vs. Fish Oil for Joint Pain: What the Studies Actually Show

Posted By under Joints & Inflammation , , , , , , , ,

If your knees ache in the morning and you’ve been told omega-3s might help, you’ve probably ended up staring at two bottles in the supplement aisle: fish oil, which is cheap and everywhere, and krill oil, which costs more and promises to be the smarter molecule. The question you’re really asking is simple. For a sore joint, does the more expensive one earn its price?

I sell krill oil for a living, so you’d expect me to tell you it does. Instead I’m going to walk you through what the trials actually found, including the one I’d least like to talk about — a large, well-run 2024 study that tested krill oil for exactly this purpose and came up empty. The honest answer is that the science here is genuinely mixed, there is no clean head-to-head trial pitting krill against fish oil for joint pain, and the gap between the two forms is almost certainly smaller than the marketing on either bottle would have you believe.

Here’s the longer version, because the details are where the real answer lives.

First, the uncomfortable part: there’s no true head-to-head trial

People search “krill oil vs fish oil for joints” expecting that somewhere, someone ran the obvious experiment — same people, same joints, half on krill and half on fish oil, and measured who hurt less. As far as the published literature goes, that trial doesn’t exist. What we have instead is a scatter of separate studies: some testing krill oil against a placebo, some testing fish oil against a placebo, and a handful comparing how much omega-3 each one gets into your blood. To answer the comparison question, you have to lay those studies side by side and reason across them, which is a weaker kind of evidence than a direct contest. Anyone who tells you krill “beats” fish oil for joints is extrapolating, not quoting a result. Keep that in mind for the rest of this, including the parts where I’m doing the same thing.

What the krill oil joint trials actually found

Krill oil has been tested against placebo for knee pain three notable times, and the results don’t line up as neatly as I’d like.

The first, a small 2016 randomized trial in adults with mild knee pain, found that 2 grams a day improved pain during sleep and standing over 30 days. Encouraging, but small and short.

Then came the study krill’s defenders love to cite: a 2022 multicenter trial published in the American Journal of Clinical Nutrition00084-3/fulltext) (Stonehouse et al.), 235 adults with mild-to-moderate knee osteoarthritis, 4 grams of krill oil a day for six months. It found statistically significant improvements in WOMAC scores for stiffness, physical function, and total knee score versus a placebo oil. Notably, the people who improved the most were those who started with the highest inflammation, measured by elevated baseline CRP — a clue that omega-3s may do more for an inflamed joint than a merely worn one. This was, at the time, the largest and most rigorous krill-for-knees study on record, and it was a genuine win.

And then came the one I owe you. In 2024, a team at Monash University published a 262-person trial in JAMA — patients with clinical knee osteoarthritis who had real pain and visible inflammation (effusion-synovitis) on MRI, given 2 grams of krill oil a day for 24 weeks. The result: no improvement in knee pain over placebo. The mean difference on a 100-point pain scale was 0.3 points, with a P value of 0.94, which in plain English means the two groups were indistinguishable. The authors concluded the data “does not support” krill oil at that dose for this population.

So one large positive trial, one large negative trial, in the same disease, a couple of years apart. What separates them? Probably three things: the negative trial used a lower dose (2 grams vs. 4), it deliberately enrolled people with more advanced, visibly inflamed joints, and the placebo group happened to improve a lot on its own — which is maddeningly common in pain research. None of that lets me wave the 2024 result away. The most you can honestly say is that krill oil may help milder, inflammation-driven knee pain at a high enough dose, and that the evidence is far from settled. A newer 2025–2026 pilot study is now testing 4 grams a day in older adults with more severe chronic pain, mostly to establish whether people will stick with that dose — which tells you the researchers themselves think dose and adherence are the open questions.

What fish oil’s own joint evidence looks like

Fish oil doesn’t get a free pass here either. Its evidence for osteoarthritis is in roughly the same boat: suggestive, inconsistent, and limited by small, biased studies.

A 2023 meta-analysis in the Journal of Orthopaedic Surgery and Research pooled the omega-3 osteoarthritis trials and concluded that supplementation does help relieve pain and improve joint function — but flagged that the underlying evidence is low quality, drawn from only a handful of trials with a high risk of bias. A separate 2020 trial in Rheumatology Advances in Practice found that DHA-rich fish oil reduced osteoarthritis-specific pain in overweight, sedentary older adults over 16 weeks. And a thoughtful 2024 review in Arthritis Care & Research by Felson and colleagues looked across the essential-fatty-acid-and-osteoarthritis literature and landed on a cautious “maybe, for some people, modestly” — which is about the most honest summary anyone has offered.

One detail worth carrying forward: across this research, EPA appears to be the omega-3 with the strongest anti-inflammatory effect. That matters because EPA-to-DHA ratios differ between products, and a high-EPA fish oil concentrate may, on the inflammation front, have an edge that has nothing to do with whether the oil came from a fish or a krill.

The bioavailability argument — and why it matters less for joints than the label implies

Here’s where krill oil’s marketing does its heaviest lifting. Krill oil carries its EPA and DHA in phospholipid form, while standard fish oil carries them as triglycerides or ethyl esters. Phospholipids mix more readily into the watery contents of your gut, so they tend to absorb a bit more efficiently. A network meta-analysis published in October 2024 supports this: across dozens of studies, the phospholipid form showed superior absorption, especially at lower doses.

That’s a real advantage — but notice what it is and isn’t. “More efficiently absorbed per milligram” is not the same as “more total omega-3 in your blood.” Krill oil bottles usually contain less EPA and DHA per gram than concentrated fish oil, so the absorption edge often just offsets the lower payload. In fact, a separate dose-matched trial found no difference in the EPA and DHA your red blood cells end up with after four weeks of krill versus fish oil. For your joints specifically — which care about how much omega-3 reaches the tissue over months, not how slickly it crossed the gut wall on day one — the phospholipid story is more elegant than it is decisive. It’s a reason to consider krill, not a reason to be certain about it.

The lever that actually moves the needle: dose and consistency

Strip away the form wars and a quieter pattern emerges from all of these trials. The studies that worked tended to use real doses — 2 to 4 grams of oil daily, often delivering well over a gram of combined EPA and DHA — taken consistently for months. Omega-3s are not aspirin. They don’t switch off a sore joint in an afternoon; they slowly shift the balance of inflammatory signaling, and that takes 8 to 12 weeks of not missing days before you can fairly judge whether it’s doing anything.

This is the unglamorous truth that both industries would rather not lead with: the person who takes a cheap fish oil every single morning for three months will almost certainly do better than the person who buys a premium krill oil and remembers it twice a week. Whatever modest benefit omega-3s offer your joints, it is entirely hostage to whether you actually keep taking them. That, and not the molecular form, is where most people lose the benefit.

So which should you take?

If you’ll take either one faithfully, the honest expectation is similar — a modest improvement for some people, especially if your joint pain is inflammation-driven and your starting omega-3 intake is low, and little to nothing for others. That’s not a satisfying answer, but it’s the true one.

Where the choice genuinely tilts toward krill oil is tolerability. The most common reason people quit fish oil is the fishy reflux and aftertaste, and krill oil’s phospholipid form tends to cause far less of it. If burps are what’s stopping you from being consistent, then krill solves the only problem that actually matters — it gets you to keep taking it. Where the choice tilts toward fish oil is cost and dose: if you need a high daily gram-count of EPA and DHA and price is a constraint, a concentrated fish oil delivers more omega-3 per dollar, and consistency is easier to afford. And if your pain is significant and persistent, the most useful thing this article can tell you isn’t which oil to buy — it’s to talk to a clinician about whether omega-3s belong in your plan at all, because for advanced osteoarthritis the 2024 trial is a real cautionary note.

A note on Captains

We make a krill oil, so you’d be right to read everything above with a raised eyebrow. But the reason I’ll point you to the 2024 null result instead of burying it is the same reason our oil is mechanically extracted with no chemical solvents at any stage and ships with a full certificate of analysis for every batch: if we’re going to ask you to trust what’s in the bottle, we have to be straight about what it can and can’t do. Krill oil is a clean, well-absorbed, easy-to-tolerate way to get your omega-3s, and for the right person with the right joint, it may help. It is not a cure for an arthritic knee, and anyone selling it as one is selling you something we won’t. Honest answer, not a pitch. — captainskrilloil.com

Does Krill Oil Expire? What “Rancid” Actually Means in an Omega-3 Bottle

Posted By under Krill Oil 101 , , ,

Yes, krill oil expires — but not the way milk expires, and not always the way the printed date on the bottle suggests. The date stamped on the box is a manufacturer’s best-guess about when the oil will still meet its label claims under reasonable storage. The thing you actually care about is something the date can’t tell you: whether the oil inside has gone rancid. Those are two different questions, and the gap between them is where most of the confusion lives.

Here’s the honest short version. Omega-3 oils — krill, fish, algae, all of them — are chemically fragile. The same thing that makes them good for you, all those reactive double bonds in the EPA and DHA, also makes them eager to react with oxygen. When they do, the oil oxidizes. Past a certain point we call that rancid. A rancid omega-3 isn’t just less effective; the oxidation products it carries may actively work against the reason you took it in the first place. So the real question isn’t “what’s the expiration date” — it’s “how do I know if this oil is fresh, and how do I keep it that way.” And the good news is you already own the two tools that answer it: your eyes and your nose.

What “rancid” actually means at the molecular level

Rancidity is just oxidation that’s gone far enough to notice. It happens in two stages, and the distinction matters because it’s the reason your nose works as well as it does.

In the first stage, oxygen attacks those fragile double bonds and forms compounds called peroxides. This is primary oxidation. Peroxides themselves are mostly tasteless and odorless. But they’re unstable, and they break down into the second wave: the aldehydes and ketones of secondary oxidation. These are the molecules you actually smell and taste — the “off,” fishy, paint-thinner note of an oil that’s turned (Global Organization for EPA and DHA Omega-3, “Oxidation in Omega-3 Oils: An Overview”). So when someone says an oil is “rancid,” they usually mean secondary oxidation has produced enough of those compounds to taste or smell. Your senses are tuned to exactly the stage that matters.

The market really does have a freshness problem

This isn’t us being dramatic. Independent testing has repeatedly found that a startling share of omega-3 supplements on shelves are already oxidized by the time you buy them, with results varying widely by formulation and delivery form (Jackowski et al., Journal of Nutritional Science, 2015; George Washington University School of Medicine, “Tests Find Many Popular Omega-3 Supplements Are Rancid”). The debate over exactly how bad it is, and how much it matters for health, is still live among researchers (NutraIngredients, “Fish oil oxidation: experts debate the science and health impacts,” December 2025).

Now here’s where I’ll part ways with a lot of the industry. The standard answer to “how fresh is it” is a lab score called TOTOX — total oxidation, built from those peroxide and anisidine measurements. And TOTOX is a real number. But I’ll be straight with you about why we don’t build our pitch around it. It’s an expensive test. Its accuracy and relevance to a sealed, finished softgel are more debatable than the marketing lets on — a single TOTOX figure on a spec sheet is a snapshot of one sample at one moment, not a guarantee of what’s in the capsule in your hand. And almost no brand prints it for you anyway. So you can chase a lab number that’s costly, contestable, and usually hidden — or you can do what fishermen have always done and use your senses. We think the senses win.

The honest caveat I owe you: the science on what oxidized omega-3 does to a human being is genuinely unsettled. The flavor and potency loss is not in dispute — a rancid oil tastes bad and delivers less intact EPA and DHA. Whether the byproducts cause measurable harm at the doses people swallow is the harder question, and nobody has run the long, clean human trial that would settle it. So I won’t tell you rancid fish oil will hurt you. I’ll tell you it’s a waste of money and possibly counterproductive, and that “fresh or don’t bother” is the only sane policy.

Krill oil’s twist: astaxanthin is a real bodyguard — and your color gauge

Krill oil has a feature fish oil doesn’t, and it happens to be the reason the eyeball test works so well. Antarctic krill oil naturally contains astaxanthin, the red carotenoid that gives the oil its deep color and acts as a built-in antioxidant — a bodyguard standing between the omega-3s and the oxygen. This is real, and it’s one reason krill oil can be more oxidatively stable than an unprotected fish oil.

But “more stable” is not “immune.” Recent storage research on Antarctic krill oil shows that the astaxanthin, the tocopherol, and the intact phospholipids steadily decline as the oil ages, with oxidation products rising in their place (Springer, European Food Research and Technology, 2025; ScienceDirect, “Lipid oxidation mechanisms of Antarctic krill oil during storage,” 2025). Here’s why that’s useful to you: as the bodyguard gets spent, the color fades. A krill oil that has lost its deep red has likely burned through most of its protection. The pigment isn’t just marketing — it’s a gauge you can read with your own eyes.

So how long does it actually last — and what does the date mean?

For a properly made, properly packaged krill oil, an unopened shelf life of about two years is typical, and that’s roughly what the printed date reflects. Encouragingly, most of an oil’s oxidation tends to happen before you ever get it — during raw-material handling, processing, and encapsulation. Once the oil is sealed inside a softgel with its antioxidants intact and boxed away from light, a good product holds up well. The capsule shell is itself an oxygen barrier, which is part of why softgels generally outlast bottled liquid oil you reopen daily.

That last point is the practical key. The date assumes sensible storage. It does not survive a sunny windowsill, a car in July, or the cabinet above the stove. Heat and light tear through the astaxanthin and accelerate everything — an oil with eighteen months left on the date can be functionally rancid in a few hot weeks. The date is a proxy for freshness under good conditions; how you store it is what makes the proxy true or false.

How to tell if yours has turned — no lab required

You don’t need a test. You need the two senses you brought with you.

Start with color. Fresh krill oil is a deep, confident red — that’s the astaxanthin doing its job. An oil that’s faded toward pale orange or brown has likely spent most of its antioxidant protection. Color is the cheapest freshness test there is, and for krill oil specifically it’s a genuinely good one.

Then the nose. Break one capsule open. A fresh krill oil smells faintly of the sea — clean, mild, a little shellfish. A rancid one smells sharp, sour, paint-like, or aggressively fishy in the bad way. Taste confirms it: fresh is neutral to mildly marine, rancid is bitter and lingering. And if a supplement is giving you fishy burps or a touch of nausea — symptoms people often blame on omega-3s as a category — oxidation is a common culprit rather than the oil itself (InnovixLabs, “Oxidized & Rancid Fish Oil”). Deep red and clean as the sea? It’s good. Faded or sharp? Toss it — ours or anyone’s.

How to keep it fresh: cool, dark, dry, sealed — not the fridge

Keeping omega-3 fresh comes down to denying oxidation its inputs, and there’s one piece of common advice we flatly disagree with: don’t refrigerate it.

It sounds responsible, but the fridge works against you in two ways. First, it’s a humid environment, and moisture is no friend to a softgel. Second — and this is the one that actually ruins bottles — it’s easy to freeze a krill oil by mistake in a cold fridge or a freezer door. A frozen softgel can split, and once the shell fails and air reaches the oil, it oxidizes fast. You took the one thing protecting the oil, the sealed capsule, and broke it.

So skip the fridge. Keep it cool (stable room temperature, away from the stove and any heat source), dark (leave it in its opaque box or a cupboard, not on the counter), dry, and sealed (close it tightly; don’t decant a month’s supply into a daily pill organizer where each capsule sits exposed to air and light). And buy a quantity you’ll finish within a few months rather than the bulk jar that saves a few dollars and then slowly oxidizes on your shelf.

A note on Captains

We get this question a lot, usually phrased as worry: is my krill oil still good? The reason we can answer it plainly is that we don’t hide behind a lab number we hope you won’t understand. We tell you to use your eyes and your nose, because on this particular product they genuinely tell you what you need to know: deep red and clean means the astaxanthin is still on the job; faded or sharp means it’s done. Our oil is mechanically extracted with no chemical solvents at any stage, and the astaxanthin in it is the krill’s own, not something dripped in afterward — which is exactly why the color is worth trusting. Store it cool, dark, and dry, keep it out of the fridge, finish it within a few months of opening, and if it ever smells like a tackle box, throw it out. Honest answer, not a pitch. — captainskrilloil.com

Same Molecule, Different Vehicle: Phospholipid vs. Triglyceride Omega-3s

Posted By under Krill Oil 101 , , , , ,

Here’s the honest version of this article up front: if you’re already taking a fish oil supplement and tolerating it fine and taking it every day, the form of omega-3 you’re getting probably doesn’t matter enough to switch. The intake is the point. The form is a detail.

But if you’ve tried fish oil and quit — because of the burps, the reflux, the lingering taste, or just the size of the capsule — the form might be exactly the reason you quit. And that makes it worth understanding.

This is an explainer on the three main molecular forms omega-3 supplements come in, what the absorption research actually shows, and when the difference matters enough to care about.

Three Forms, One Fatty Acid

EPA and DHA — the two omega-3 fatty acids your body actually uses — are the same molecules regardless of how they’re packaged. The difference between supplements is the vehicle those molecules ride in from your gut into your bloodstream. There are three common ones:

Ethyl esters (EE). The cheapest form. Created during the concentration process when omega-3s are chemically bonded to ethanol. This is what most bargain-shelf fish oil capsules contain. Your body has to strip the ethanol bond before it can absorb the EPA and DHA, which makes it the slowest and least efficient form. Ethyl esters also depend heavily on dietary fat for absorption — take them on an empty stomach and you lose a significant chunk of the dose.

Triglycerides (TG). The natural form found in fish tissue. Three fatty acid chains attached to a glycerol backbone. Your pancreatic lipase knows exactly what to do with this structure — it’s the same form you’d get from eating salmon. Better absorbed than ethyl esters, and the form used in most mid-to-premium fish oil products. Re-esterified triglycerides (rTG) are a concentrated version that tests at the top of the bioavailability charts alongside phospholipids.

Phospholipids (PL). The form found in krill. Instead of three fatty acid chains on a glycerol backbone, you get two fatty acid chains plus a phosphate head group — the same architecture your own cell membranes use. This structural similarity means phospholipid omega-3s integrate into micelles more readily in the gut and don’t require the same enzymatic processing as triglycerides or ethyl esters before absorption (Pham et al., 2024). About 60–70% of the omega-3s in krill oil are bound to phospholipids, with phosphatidylcholine being the dominant carrier.

What the Absorption Studies Actually Show

The bioavailability question has been studied enough times that a rough hierarchy has emerged. The 2025 consensus, drawn from studies published between 2018 and 2024, ranks the forms: rTG ≈ PL > TG > EE. Re-esterified triglycerides and phospholipids sit at the top, natural triglycerides in the middle, ethyl esters at the bottom (MVS Pharma, 2024 review).

A 2024 network meta-analysis — the most comprehensive comparison to date — pooled data across multiple dosage levels and molecular forms. At doses below 2,000 mg (which covers most consumer supplements), krill oil’s phospholipid form showed enhanced area-under-the-curve plasma levels compared to standard fish oil triglycerides (Clinical Nutrition ESPEN, 2024). The advantage was most pronounced at low doses — exactly the range where most people are actually supplementing.

A 2023 randomized, double-blind crossover study compared phospholipid-enhanced fish oil against krill oil directly. The absorption totals were similar, but the profiles differed: the phospholipid forms showed higher, earlier plasma peaks, meaning the omega-3s reached the bloodstream faster (PubMed, 2023).

I want to be careful here. “Better absorbed” is not the same thing as “better for your health.” A 2024 meta-analysis of 64 randomized controlled trials found no significant difference in triglyceride, LDL, HDL, or total cholesterol levels between krill oil and fish oil. The absorption advantage doesn’t always translate into measurably different clinical outcomes — at least not in the endpoints that have been studied so far.

That said, one newer trial pushes back on that conclusion slightly. A 2026 pilot RCT in BMC Complementary Medicine and Therapies randomized 47 patients with hypertriglyceridemia to phospholipid-bound omega-3s (825 mg/day EPA+DHA) or standard omega-3s (903 mg/day EPA+DHA) for 12 weeks. The phospholipid group’s mean triglycerides dropped 9.1 mg/dL; the standard group’s rose 15.2 mg/dL. More notably, 36.4% of the phospholipid group hit the ≤150 mg/dL target versus 13.6% in the standard group (PMC, 2026). It’s a small, pilot study — not proof. But the direction is interesting, and it’s the first head-to-head clinical outcomes trial between the two forms.

The Omega-3 Index Difference

The omega-3 index — the percentage of EPA and DHA in your red blood cell membranes — is arguably a better measure of whether the omega-3s you’re swallowing are actually making it into your cells. The target is 8% or higher. Most Americans sit at 4–5%.

A controlled crossover trial gave 24 healthy volunteers either krill oil or fish oil, each providing 600 mg of omega-3s, for four weeks with washout periods between. Krill oil raised the omega-3 index more than fish oil at the same dose. EPA levels in red blood cells were significantly higher after the krill oil phase. DHA rose compared to control in the krill oil group but didn’t reach significance in the fish oil group (Ramprasath et al., Lipids in Health and Disease, 2013).

An earlier comparative bioavailability study found the same pattern: the highest incorporation of EPA and DHA into plasma phospholipids came from krill oil, followed by re-esterified triglyceride fish oil, then ethyl ester fish oil (Schuchardt et al., 2011).

What this means practically: milligram for milligram, more of the EPA and DHA from phospholipid-bound omega-3s ends up in your cell membranes, where it does its work. A smaller dose of the phospholipid form can move the needle on your omega-3 index as much as a larger dose of triglyceride fish oil.

Why the Form Affects Whether You Actually Take It

This is the part that matters more than any bioavailability chart.

“Fish burps” are the single most cited reason people stop taking fish oil. The mechanism is straightforward: triglyceride oil doesn’t mix with water. It floats on top of your stomach contents. If you get any reflux — and a lot of people do — what comes up tastes like fish. The larger the capsule, the worse the problem, and standard fish oil capsules are not small.

Phospholipids behave differently in the stomach. They’re amphiphilic — one end dissolves in water, the other in fat — which means they emulsify in stomach fluid rather than pooling on top of it. This is the same reason egg yolks emulsify a vinaigrette: the phospholipids in the yolk bridge the oil and water. In practice, this means krill oil supplements are far less likely to repeat on you, and the capsules are typically smaller because the dose doesn’t need to be as large to deliver the same amount of usable EPA and DHA.

For most healthy adults, this is a comfort-of-use difference. Annoying but manageable. But for people with GI sensitivity, people on GLP-1 medications (where nausea and reflux are already daily features), or anyone who has quietly stopped taking fish oil because the experience was unpleasant — this is the difference between a supplement they take and a supplement that sits in the cabinet.

Consistency beats potency. A 500 mg dose you take every day will always outperform a 2,000 mg dose you take when you remember, which will always outperform a 3,000 mg dose you bought once, tried twice, and abandoned.

Astaxanthin: The Bonus You Didn’t Ask About

Krill oil is red. That color comes from astaxanthin, a carotenoid antioxidant that krill accumulate from the microalgae they eat. It’s not added during manufacturing — it’s part of the animal.

Astaxanthin does two practical things in the context of an omega-3 supplement. First, it protects the omega-3 fatty acids themselves from oxidation. Omega-3s are polyunsaturated, which means they have multiple double bonds in their carbon chain — and each one is a site where oxygen can attack the molecule and turn it rancid. Fish oil manufacturers add synthetic antioxidants (usually tocopherols) to slow this down. Krill oil comes with its own antioxidant already built in (Marine Drugs, 2021).

Second, astaxanthin has its own modest evidence base as an anti-inflammatory and antioxidant in human tissue — separate from whatever it does for the oil in the capsule. I wouldn’t buy a supplement for astaxanthin alone, but getting it included in your omega-3 isn’t nothing.

Where the Form Doesn’t Matter

If you eat fatty fish twice a week — real fatty fish, not tilapia — you probably don’t need to think about any of this. Salmon, sardines, mackerel, and anchovies deliver omega-3s in their natural triglyceride form, packaged with the fats and proteins your digestive system evolved to handle. No supplement form will beat that.

If you’re taking a high-quality re-esterified triglyceride fish oil and tolerating it well, your absorption is already near the top of the hierarchy. Switching to krill oil would give you a slightly different absorption profile and smaller capsules, but the practical difference in outcomes is unlikely to be meaningful. Don’t fix what isn’t broken.

If cost is the primary constraint, a standard triglyceride fish oil taken consistently with a meal containing some fat will get the job done. It won’t absorb as efficiently as rTG or phospholipid forms, but the gap narrows when you take it with food, and the most important variable is still whether you take it at all.

Where It Does Matter

The form starts to matter when tolerability is the bottleneck — when you’ve tried fish oil and the experience was bad enough that you stopped. It matters when the dose needs to be small because appetite is low, stomach space is limited, or nausea is already part of the picture. It matters when you want to move the omega-3 index with the minimum effective dose rather than swallowing four large capsules a day.

It matters, in other words, for exactly the people who are most likely to be under-supplemented: the ones who tried and quit.

Captains Krill Oil™ is one option in this space. We make an honest, small-batch phospholipid omega-3 product — always have. But the more important thing than which brand you pick is that you’re getting EPA and DHA from somewhere, in a form you’ll actually take, at a dose that moves your number. The molecule is the point. The vehicle is just how it gets there.

If you want to know where you stand, the omega-3 index test costs about $50 and gives you a real number. Target is 8% or higher. That number matters more than which bottle is on your shelf.

Is Krill Oil Extracted With Hexane? What’s Actually in the Bottle

Posted By under Krill Oil 101 , , ,
If you’ve fallen down a late-night supplement rabbit hole and ended up on the question of how krill oil is made — congratulations, you’re asking the question almost no krill oil website wants to answer directly. The labels say things like “pure,” “premium,” “Antarctic-sourced,” and a great many of them say nothing at all about how the oil got out of the krill and into the capsule. The implication is that you don’t need to know. You do, a little. Because the way krill oil is extracted determines what residues might tag along, how much of the good stuff (phospholipids, astaxanthin, omega-3s) survives the process, and how rancid the oil is by the time you swallow it. The short, honest answer is: most premium krill oil sold in 2026 is not extracted with hexane. The longer answer involves a small zoo of extraction methods, a 2024 European safety re-evaluation, and a label term — “solvent-free” — that means something more specific than it sounds. Here’s the whole picture, from the boat down.

How krill oil is actually extracted (and why it matters)

Krill are tiny. About the size of a paperclip, and roughly 80% water by weight. To turn a trawler-load of fresh Antarctic krill into a teaspoon of dark-red oil, you have to separate the lipids (the oil) from everything else — protein, water, chitin shells, minerals. That separation is the extraction step, and the industry uses several different approaches. The traditional method, going back decades, is a two-step solvent extraction with acetone followed by ethanol. Acetone pulls out the neutral lipids (the triglycerides), and ethanol pulls out the polar lipids (the phospholipids — the part of krill oil that gives it its bioavailability edge). Both solvents are then evaporated off, and what’s left is krill oil. It works, but it’s laborious, and acetone in particular is unpopular with cleaner-label brands. Most modern premium krill oil is extracted using ethanol alone, sometimes combined with low-temperature fractionation to separate the phospholipid-enriched fraction from the neutral oil. Aker BioMarine’s Flexitech process — which produces Superba 2 and Superba Boost, two of the most-sold krill oil ingredients on the planet — uses only ethanol and relies on low temperature and efficient fractionation methods, with no high-temperature molecular distillation and no other solvents. Rimfrost, the other major krill oil producer, holds a family of patents on a solvent-free process that cooks fresh krill at around 90°C, then separates the oil mechanically with a decanter and screw press — no chemical solvents at any stage. A 2019 head-to-head comparison published in Food Science & Nutrition tested extraction efficiency across the main methods and found this order, from least to most efficient at pulling lipids from krill meal: n-hexane (69.5%) < supercritical CO₂ (71.2%) < subcritical n-butane (82.6%) < ethanol (93.6%) < subcritical dimethyl ether (93.8%). Hexane, in other words, is actually the worst solvent for getting oil out of krill. It’s near the bottom of every modern industrial extraction process for this particular raw material. There’s a reason no major krill oil brand markets itself on hexane extraction: nobody uses it as a primary solvent for krill, because it doesn’t work as well as ethanol. That doesn’t mean hexane is never anywhere near the supply chain. It’s still common in vegetable oil extraction, in some fish oil refining processes, and as a processing aid in concentrated omega-3 products. But for krill oil specifically, hexane is mostly a research-paper benchmark, not a production tool.

The 2024 EFSA re-evaluation: what changed, and what didn’t

The reason hexane is on anyone’s radar right now is a quietly important regulatory moment. In 2024, the European Food Safety Authority published a technical report on the need to re-evaluate the safety of technical hexane as an extraction solvent in food. The headline finding was not “hexane is unsafe.” It was “we don’t actually have enough data to confidently say it’s safe at modern exposure levels, especially for infants and young children.” A few specifics worth knowing. Technical hexane is not a single chemical — it’s a mixture of n-hexane and related compounds whose impurities are poorly specified in current regulatory frameworks. Human absorption of n-hexane is well documented. And the exposure assessment models in use since the 1990s may have underestimated how much residual hexane actually shows up in food and food ingredients today. EFSA’s official position is that current safety assessments remain valid and products using hexane continue to be considered safe under existing regulations — but the agency is collecting fresh data and the re-evaluation is ongoing. The toxicology that drove the original concern is real, but it’s almost entirely occupational. n-Hexane is a recognized peripheral neurotoxin first identified in 1964, and the cases that ended up in the medical literature came from shoe factories, printing plants, and furniture workshops with poor ventilation, where workers inhaled large quantities of vaporized solvent every day for years. The neurotoxic effects are caused by a metabolite (2,5-hexanedione) that accumulates with chronic high-dose exposure. The doses involved in residual food contamination are several orders of magnitude lower. There is no clinical evidence that consumer-level exposure to hexane residues in food causes neuropathy. But it’s also true that nobody has run the long-term study at modern exposure levels in infants and small children, and that’s the gap EFSA is now asking about. The practical takeaway: if you’re buying a premium krill oil from a major brand in 2026, hexane probably isn’t in the supply chain in any meaningful way. If you’re buying the cheapest no-name omega-3 you can find on a marketplace site, you might not know.

What “solvent-free” actually means on a label

“Solvent-free” is one of those phrases that means a specific thing in a regulatory document and a fuzzier thing on a supplement bottle. There are two ways the term gets used. The first is mechanical extraction without chemical solvents at any stage. This is the Rimfrost-style approach — cook the krill, separate the oil physically using temperature, gravity, and pressure. No ethanol, no acetone, no hexane, no CO₂. The yield is lower and the equipment cost is higher, but the oil that comes out has no solvent residues to speak of because no solvent was ever introduced. This is the most defensible version of “solvent-free.” The second, more common, version is solvent extraction followed by complete solvent removal. Ethanol-extracted krill oil, once the ethanol has been distilled off and the residual measured below regulatory limits, is sometimes marketed as “ethanol-free” or “free from harmful solvents.” That’s technically accurate — the finished oil contains only trace solvent — but it’s not the same thing as having never used a solvent. The distinction matters more to clean-label purists than to anyone tracking actual health outcomes, but if the label phrase matters to you, it’s worth asking the brand to clarify which definition they’re using. A third version is the catch-all marketing phrase “no chemical processing,” which can mean anything from “we use only ethanol, which is a chemical” to “we cook and press.” When you see that phrase, the European food consumer information body EUFIC notes that you usually have to look at the manufacturer’s technical documentation to know what’s actually going on, because the label doesn’t tell you.

What residue levels actually look like

For perspective on how small “residue” gets in finished oil: EU regulations cap residual n-hexane in fats and oils at 1 mg/kg (1 ppm). For specific ingredients like degreased flours and protein products it’s higher, but for the oils most likely to end up in a supplement, the limit is parts-per-million. Modern analytical methods can detect hexane down to the parts-per-billion range, and well-run ethanol-extraction facilities typically report residual ethanol in finished krill oil well below the regulatory ceiling. Ethanol itself, for what it’s worth, is the same molecule as the alcohol in beer and wine. Residual ethanol in a finished krill oil capsule is measured in micrograms per dose — orders of magnitude below anything you’d get from a sip of a beverage. The honest concern with ethanol extraction isn’t toxicity; it’s whether the temperatures used to remove it damaged the omega-3s or the astaxanthin on the way through. That’s a process-quality question, not a solvent-residue question.

The questions actually worth asking

If you care enough about how your krill oil was made to read this far, here are the questions that separate a transparent supplier from a cagey one: What solvent, if any, is used in primary extraction? “Ethanol only” and “solvent-free mechanical” are both legitimate honest answers. “Proprietary” is a flag. The answer should be one sentence and shouldn’t require legal review. What’s the residual solvent specification, and is it tested per batch? A real supplier can tell you the spec (e.g., “ethanol < 50 ppm per batch, certificate of analysis available on request”). A reseller usually can’t. What temperatures does the oil see during processing? Krill phospholipids and astaxanthin are heat-sensitive. Low-temperature processing (under 60°C for most steps) preserves more of what makes krill oil worth taking in the first place. What’s the TOTOX value (total oxidation) of the finished oil? Industry voluntary spec is under 26; the best krill oils come in well below 10. This tells you how rancid the oil is when it gets to you — which, for any omega-3 supplement, matters more than almost anything else. A supplier that can answer those four questions in plain English is operating in good faith. A supplier that can’t is hoping you won’t ask.

A note on Captains Krill Oil

This whole article was triggered by a question we get every few weeks: “Is your krill oil extracted with hexane?” The answer is no. The honest, longer answer is that the entire premium krill oil industry has moved away from hexane over the last fifteen years, mostly because it’s a worse solvent for this particular raw material — not because of any high-minded clean-label crusade. Captains Krill Oil is mechanically extracted — cooked and pressed, no chemicals at any stage — with full COA documentation per batch. If you want the spec sheet, ask and we’ll send it. If you’d rather buy from somebody who uses a different process, that’s a choice too. The point is that you should be able to find out, in plain English, before you swallow it. That, more than any single extraction method, is what separates a supplement worth taking from one that isn’t.
Sources: EFSA technical report on hexane re-evaluation (2024) · Sun et al., Food Science & Nutrition (2019), ethanol-hexane vs. subcritical extraction comparison · Aker BioMarine Flexitech patent coverage · Rimfrost solvent-free extraction patent · EFSA P12-10 re-evaluation rationale (2025) · PubMed: n-hexane toxic neuropathy case series · Medscape: n-hexane-related peripheral neuropathy review · EUFIC: is hexane in food a cause for concern? · SGS Fresenius: hexane in food, risk assessment, analysis

Should You Take Omega-3s While on Ozempic, Wegovy, or Mounjaro?

Posted By under Metabolic Health , , , , , , ,

It’s a fair question, and one that more people are starting to ask now that GLP-1 medications have moved from niche diabetes prescriptions into mainstream weight-loss medicine. If a drug works by making you eat less — sometimes a lot less — then it’s worth asking what nutrients are quietly going missing in the calories you no longer consume. Omega-3s are one of the first ones I’d look at.

The short answer: there’s no peer-reviewed study yet that has specifically measured EPA and DHA status in people taking semaglutide or tirzepatide. But the underlying math is hard to argue with. People on GLP-1 medications eat 20–35% fewer calories. They also disproportionately cut back on foods they no longer crave or tolerate well — which, for many Americans, includes the fish that already wasn’t on their plate very often. If your omega-3 intake was marginal before you started Ozempic, there’s a decent chance it’s now genuinely low.

This post walks through what we know, what we don’t, and what the practical answer actually looks like if you’re on one of these drugs and trying to do right by your long-term health.

How GLP-1 Drugs Change What You Actually Eat

GLP-1 receptor agonists — the class that includes semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide — work by mimicking a gut hormone that signals fullness to the brain and slows gastric emptying. The result, well documented in trials going back to the original STEP and SURMOUNT studies, is a sustained 15–20% reduction in body weight over 12 to 18 months for most people on a therapeutic dose (NEJM, 2023).

That weight loss comes from a real, measured drop in caloric intake. But it’s not just calories that fall. A 2025 narrative review in the International Journal of Obesity noted that GLP-1 users frequently report changes in food preference — protein-rich foods, fatty foods, and strong-smelling foods often become unappealing — and that early satiety means the meals people do eat are smaller and less varied (Nature, 2025). Clinicians treating this population now routinely watch for shortfalls in protein, iron, vitamin B12, vitamin D, calcium, and thiamine (Mass General Advances, 2025).

Omega-3s aren’t typically on that clinician checklist yet. They probably should be.

Why Omega-3s Get Squeezed Out First

Most Americans get their EPA and DHA from a fairly narrow set of foods: fatty fish (salmon, sardines, mackerel, anchovies), the occasional tuna can, and supplements. That’s about it. Plant-based ALA from flax or walnuts converts to EPA and DHA at a rate of roughly 5–10% and 0.5% respectively, so it doesn’t realistically move the needle.

The average U.S. adult already takes in only about 0.1 grams of combined EPA and DHA per day (American Heart Association, 2023) — roughly a third of the most commonly cited 250–500 mg target, and a small fraction of the 1–2 grams that cardiovascular guidelines often suggest for people with elevated risk. A global 2025 analysis of red blood cell omega-3 status, covered in Science Daily and built on data from dozens of countries, estimated that roughly three-quarters of the world’s population has an omega-3 index below the 8% target associated with lower cardiovascular mortality (Science Daily, 2025; Nutrition Insight, 2025).

So the baseline is already poor. Now layer GLP-1-induced appetite suppression on top. Two things tend to happen:

The fish that was already infrequent gets eaten less often, because the meal is smaller and fish — especially oilier, stronger-smelling fish — is exactly the kind of food that some GLP-1 users start avoiding. And the supplemental fish oil capsule that was already in the cabinet often gets skipped, because nausea and reflux are common GLP-1 side effects, and fish oil is well known for “fish burps” that make those symptoms worse (Ubie Health).

The end result is a population that was already running low on EPA and DHA, eating less of the few foods that contain them, while skipping the supplement that was supposed to fill the gap. It’s not paranoia to think this is creating a quiet deficiency problem.

What the Research Says So Far

To be honest about the state of the evidence: there is not yet a published randomized trial that has measured omega-3 index in semaglutide users before and after a year of treatment. That study is the obvious next thing somebody should run, and I’d guess it’s in the works at one of the obesity research centers. Until it lands, we’re reasoning from adjacent data.

What we do have:

A 2025 PMC review of n-3 PUFAs in obesity and metabolic disease noted that omega-3 supplementation during rapid weight loss helps prevent unfavorable changes in fatty acid tissue composition and “may help prevent essential fatty acid deficiency” — language that’s about as direct as nutrition research usually gets when warning about a deficiency risk (PMC, 2025).

A 2024 Scientific Reports analysis of dietary omega-3 intake and mortality among people with cardiovascular disease found that higher dietary EPA and DHA intake was associated with lower all-cause and cardiovascular-specific mortality (Scientific Reports, 2025). The population on GLP-1 drugs overlaps heavily with the population that has cardiovascular risk, which makes the stakes of any quiet shortfall higher, not lower.

And the lean mass literature is worth flagging: GLP-1 weight loss includes a meaningful share of lean tissue — up to 15–40% of total weight lost can be lean body mass (Mass General Advances, 2025; Healio, 2025). Omega-3s aren’t a magic muscle-preservation tool, but multiple controlled trials have shown they modestly support lean mass retention when paired with adequate protein, particularly in older adults. If you’re losing weight quickly and want to lose less muscle in the process, this is one of the few supplements that has reasonable evidence behind it.

None of this is proof that GLP-1 users are deficient. But the direction of the arrows is consistent: lower intake, higher need, more vulnerable population.

How Much EPA and DHA Do You Actually Need?

For a healthy adult with no cardiovascular risk factors, most guideline bodies converge on 250–500 mg of combined EPA and DHA per day, which works out to about two servings of fatty fish per week (Cambridge Nutrition Research Reviews). The omega-3 index — a measurement of EPA and DHA as a percentage of red blood cell fatty acids — has a target of 8% or higher for cardiovascular protection, with most people sitting at 4–5% (PMC, Omega-3 Index and Cardiovascular Health).

For people with established cardiovascular disease or higher risk, a 2025 dose-response analysis put the suggested intake closer to 2 grams of total omega-3s per day (Scientific Reports, 2025). That’s roughly 4–8 capsules of standard fish oil, or a smaller, more concentrated dose from a higher-potency product.

If you’re on a GLP-1 and eating noticeably less than you used to, the honest framing isn’t “do I need a supplement” — it’s “what’s my actual intake right now, and is it covering the floor.” A week of food logging is usually enough to answer that. If you’re eating salmon twice a week and tolerating it fine, you’re probably okay. If your protein has shifted to lean chicken and Greek yogurt and fish has fallen off the menu, you have a gap.

Why the Form Matters When Appetite Is Low

Here’s where this gets practical, and where the choice of supplement starts to matter more than it usually does. People in normal eating mode can tolerate a 1000 mg fish oil softgel with breakfast and barely notice it. People on GLP-1s often cannot. Nausea, slowed gastric emptying, and reflux are the most common GLP-1 side effects, and oil-based supplements that linger in the stomach are exactly the kind of thing that aggravates them (Inspira Health; Ubie Health).

This is where the phospholipid form of omega-3s — the form that omega-3s naturally take inside krill, and the form they take inside the membranes of your own cells — becomes genuinely interesting rather than just a marketing talking point. A 2024 network meta-analysis of bioavailability studies found that at doses below 2000 mg, krill oil’s phospholipid-bound EPA and DHA delivered superior absorption compared to standard triglyceride fish oil (PMC, 2024 Network Meta-Analysis). A separate 2023 crossover study in healthy adults confirmed that phospholipid-bound omega-3s are more readily incorporated into plasma than ethyl ester forms (PubMed, 2023).

Practically, that means a smaller capsule of phospholipid omega-3s can deliver a comparable amount of usable EPA and DHA to a larger capsule of conventional fish oil. For someone whose stomach is already full at half the meal it used to handle, smaller-and-better-absorbed is a real advantage. The phospholipid form also tends not to repeat the way triglyceride fish oil does, which matters more than it sounds when reflux is already a regular feature of your week.

I’d be cautious about overclaiming this. The bioavailability advantage is real but modest, and a high-quality, well-tolerated triglyceride fish oil taken consistently will absolutely get the job done if that’s what you have. The question is whether you’re actually taking it. For a lot of GLP-1 users, the answer is no, because the tolerability isn’t there.

Practical Takeaways

A few things that follow from all of this:

Track what you’re actually eating for a week. Not what you used to eat — what you ate this week. If fatty fish is showing up twice, you probably don’t need to think about this further. If it’s showing up zero times and you’re three months into a GLP-1, you have a gap worth filling.

Don’t take a fish oil capsule on an empty stomach if you’re on a GLP-1. Take it mid-meal, with the fattiest part of the meal, and stay upright for at least half an hour. This is true for any omega-3 supplement, but it matters more here.

Consider the omega-3 index test if you want to know where you stand. It’s about $50, mail-order, and gives you a real number instead of a guess. Target is 8% or higher.

Mind the protein first. Omega-3s are important, but lean mass loss is the bigger nutritional concern with GLP-1s, and the answer there is 1.6–2.2 grams of protein per kilogram of body weight per day, distributed across meals, paired with resistance training (Mass General Advances, 2025). Omega-3s support that goal but don’t replace it.

Don’t assume your multivitamin is covering it. Most don’t include meaningful EPA and DHA, and the ones that do typically include amounts measured in milligrams that don’t move the needle.

Captains Krill Oil exists in this conversation only as one of several reasonable phospholipid-form options. If you’re on a GLP-1 and you’ve decided you want a smaller, better-tolerated omega-3 supplement, krill oil is a sensible category to look at, and ours is one of the longer-standing products in it. But the more important thing is that you’re getting EPA and DHA from somewhere — fish on your plate, a triglyceride fish oil capsule you actually tolerate, or a phospholipid product if the tolerability is what’s been holding you back. The form is a detail. The intake is the point.

If the science gets clearer in the next year or two — and I expect it will, because this is exactly the kind of question that gets studied once enough patients are on these drugs — I’ll update this post.

Q: Can krill oil cause gout or kidney stones?

Posted By under Safety & Interactions ,

A: Well it is a shellfish. The lawyer types would probably want me to say that seafood, shellfish, meat and some vegetables are naturally high in purines, which promotes a buildup of uric acid. This buildup may lead to gout or kidney stones.

But krill oil is highly purified and this leaves behind the purines. So for most people no, it’s not going to give you gout or kidney stones.

Q: Does krill oil cause diarrhea?

Posted By under Safety & Interactions ,

A: I would hope not! That would be a catastrophe out at sea!

Seriously, it’s very rare but I suppose it’s theoretically possible. Anything is theoretically possible. Theoretically I could catch a mermaid one day. For most people though, I’d say no. Omega-3’s have been shown to be beneficial for digestion. If it does bother your stomach in any way, try splitting up the dose and taking it with food. Say one with breakfast and one with lunch.